These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 17410017)

  • 21. Effect of age on the efficacy of adjuvant chemotherapy for resected non-small cell lung cancer.
    Ganti AK; Williams CD; Gajra A; Kelley MJ
    Cancer; 2015 Aug; 121(15):2578-85. PubMed ID: 25873330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy in elderly patients with advanced lung cancer. Part II: Treatment of non-small cell lung cancer (NSCLC).
    Honecker F; Wedding U; Bokemeyer C;
    Onkologie; 2004 Dec; 27(6):583-8. PubMed ID: 15591721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lung cancer in the elderly.
    Gridelli C; Langer C; Maione P; Rossi A; Schild SE
    J Clin Oncol; 2007 May; 25(14):1898-907. PubMed ID: 17488989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of pretreatment factors on adverse events: a pooled analysis of North Central Cancer Treatment Group advanced stage non-small cell lung cancer trials.
    Mandrekar SJ; Northfelt DW; Schild SE; Foster NR; Bot B; Marks RS; Mailliard JA; Krook JE; Maksymiuk AW; Adjei AA; Jett JR
    J Thorac Oncol; 2006 Jul; 1(6):556-63. PubMed ID: 17409917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant therapy in the elderly: making the right decision.
    Muss HB; Biganzoli L; Sargent DJ; Aapro M
    J Clin Oncol; 2007 May; 25(14):1870-5. PubMed ID: 17488985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical issues in the management of non-small-cell lung cancer and the role of platinum-based therapy.
    Socinski MA
    Clin Lung Cancer; 2004 Mar; 5(5):274-89. PubMed ID: 15086966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Gemcitabine in the first line therapy of advanced and metastatic non-small-cell lung carcinoma (NSCLC): review of the results of phase III studies].
    Langer F; Helsberg K; Schütte WH; Leschinger MI
    Onkologie; 2005 Mar; 28 Suppl 1():1-28. PubMed ID: 15802886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non–small-cell lung cancer in elderly patients: a discussion of treatment options.
    Gajra A; Jatoi A
    J Clin Oncol; 2014 Aug; 32(24):2562-9. PubMed ID: 25071101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An overview of 48 elderly-specific clinical trials of systemic chemotherapy for advanced non-small cell lung cancer.
    Hotta K; Ueoka H; Kiura K; Tabata M; Tanimoto M
    Lung Cancer; 2004 Oct; 46(1):61-76. PubMed ID: 15364134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First-line treatment for advanced non-small-cell lung cancer.
    Laskin JJ; Sandler AB
    Oncology (Williston Park); 2005 Nov; 19(13):1671-6; discussion 1678-80. PubMed ID: 16425521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-dose therapy with carboplatin and paclitaxel in non-small cell lung cancer.
    Socinski MA; Shea TC
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-45-S12-51. PubMed ID: 9331121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of non-small-cell lung cancer in the older adult.
    VanderWalde A; Pal SK; Reckamp KL
    Maturitas; 2011 Apr; 68(4):311-21. PubMed ID: 21295421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developments in the treatment of non-small cell lung cancer.
    Gkiozos I; Charpidou A; Syrigos K
    Anticancer Res; 2007; 27(4C):2823-7. PubMed ID: 17695454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of non-small-cell lung cancer in North America: the emerging role of irinotecan.
    Langer CJ
    Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):19-24. PubMed ID: 11221017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First-line combination chemotherapy for advanced non-small cell lung cancer: the Eastern Cooperative Oncology Group and Southwest Oncology Group experience.
    Sandler A
    Semin Oncol; 1999 Oct; 26(5 Suppl 15):44-51. PubMed ID: 10566611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of unfit older patients with advanced NSCLC.
    Gridelli C; Maione P; Rossi A; Palazzolo G; Colantuoni G; Rossi E
    Cancer Treat Rev; 2009 Oct; 35(6):517-21. PubMed ID: 19457617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Palliative chemotherapy for non-small cell lung cancer.
    Adelstein DJ
    Semin Oncol; 1995 Apr; 22(2 Suppl 3):35-9. PubMed ID: 7537902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-world chemotherapy treatment patterns in metastatic non-small cell lung cancer: Are patients undertreated?
    Sacher AG; Le LW; Lau A; Earle CC; Leighl NB
    Cancer; 2015 Aug; 121(15):2562-9. PubMed ID: 25891153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overview of the randomized phase III trials in non-small cell lung cancer in North America.
    Kelly K
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-2-S8-5. PubMed ID: 9207308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Caring for the Older Population With Advanced Lung Cancer.
    Presley CJ; Reynolds CH; Langer CJ
    Am Soc Clin Oncol Educ Book; 2017; 37():587-596. PubMed ID: 28561726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.